

Developer of drug discovery platform for the treatments of chronic viral infections. The company develops molecules modulating host functions for the treatment of acute and chronic viral infections and identify new intracellular therapeutic targets and molecules acting against these targets.
ENYO Pharma was founded in 2014 and its current CEO is Jacky Vonderscher. Since its inception 12 years ago, ENYO Pharma has grown to 11 employees.
| Headquarter | , Lyon 69007 France |
|---|---|
| Website | www.enyopharma.com |
| Founding Date | 2014 |
| Company Status | Private |
ENYO Pharma competitors include Biogen, MyoKardia, and Reata Pharmaceuticals. See below how ENYO Pharma compares to its competitors with CEO Rankings, Product & Services, NPS, Pricing, Customer Services, Overall Culture Score, eNPS, Gender and Diversity Scores.

No Recent Jobs found for ENYO Pharma on Comparably
Mark that you are interested and we will alert you when there are new positions available listed on Comparably

What is ENYO Pharma address?
ENYO Pharma location is at , Lyon
How many employees work in ENYO Pharma?
ENYO Pharma has 11 employees
Who are ENYO Pharma competitors?
ENYO Pharma main competitors are Biogen, MyoKardia, Reata Pharmaceuticals
Who is ENYO Pharma leadership?
are part of ENYO Pharma leadership, Jacky Vonderscher is the CEO